Ferozsons Laboratories (KAR:FEROZ) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 07, 2026)


KAR:FEROZ Ferozsons Laboratories Ltd KAR:FEROZ
76 GF Score
Price ₨411.15
GF Value ₨418.18
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Ferozsons Laboratories Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Ferozsons Laboratories's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

KAR:FEROZ vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ferozsons Laboratories Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's Margin of Safety % (DCF FCF Based) falls into.


KAR:FEROZ
76GF Score
Ferozsons Laboratories Ltd KAR:FEROZ
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued. The current stock price of ₨411.15 is trading 1.7% below its estimated GF Value™ of ₨418.18. GuruFocus considers Ferozsons Laboratories to be Fairly Valued.

Key valuation signals for KAR:FEROZ:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₨418.18 vs. price of ₨411.15 (1.7% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ferozsons Laboratories Business Description

Address 5 K.M Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
76GF Score

Get the complete analysis for KAR:FEROZ

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨411.15
Price
₨418.18
GF Value